|
|
||||||||
Regular Article |
a Fearing Research Laboratory and the Center for Reproductive Medicine,
b Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115
ABSTRACT
Apoptosis, or programmed cell death, is an important mechanism for the regulation of embryonic development and tissue homeostasis. It is coordinated by a number of molecules including the Fas-Fas ligand (FasL) system and bcl-2. The purpose of this study was to characterize the expression of these molecules in human oocytes and cumulus cells from gonadotropin-stimulated human ovaries and to determine whether the presence of soluble Fas (sFas), soluble FasL, or interferon-
in follicular fluid (FF) correlated with apoptosis in cumulus cells, oocyte maturation, and embryo quality. Levels of sFas were significantly higher in FF containing immature oocytes compared with those containing atretic oocytes (P < 0.05; FF containing mature oocytes had highly variable levels of sFas. Levels of sFas in FF did not correlate with either fertilization, embryo quality resulting from fertilized oocytes, or apoptosis rate in cumulus cells. Fas was expressed in both unfertilized oocytes and cumulus cells, whereas FasL expression was not usually detected in these cell types. Messenger RNA for bcl-2 was detectable in both freshly isolated oocytes and cumulus cells but was not demonstrable following 24 h of culture that coincided with a significant increase of apoptosis in cumulus cells. Our results indicate that soluble forms of the Fas-FasL system are present in FF from gonadotropin-stimulated human ovaries and suggest that this system may play a role in preventing oocyte atresia during folliculogenesis but is probably not important for apoptotic events in cumulus cells and oocytes after fertilizaton failure. Apoptosis in this case may be facilitated by the downregulation of bcl-2. Further studies on the expression of these molecules in follicles containing atretic oocytes and immature oocytes are needed to confirm this new hypothesis.
First decision: 20 January 2000.
1 This work was supported in part by grant AI3851502 from the National Institute of Health, Bethesda, MD, by the Fearing Research Laboratory Endowment, and by the Instituto Valenciano de Infertilidad.
2 Correspondence: Joseph A. Hill, Reproductive Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115. FAX: 617 566 7752; jahill{at}bics.bwh.harvard.edu
This article has been cited by other articles:
![]() |
G. Onalan, B. Selam, Y. Baran, M. Cincik, R. Onalan, U. Gunduz, A. U. Ural, and R. Pabuccu Serum and follicular fluid levels of soluble Fas, soluble Fas ligand and apoptosis of luteinized granulosa cells in PCOS patients undergoing IVF Hum. Reprod., September 1, 2005; 20(9): 2391 - 2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Malamitsi-Puchner, A. Sarandakou, S. Baka, N. Vrachnis, E. Kouskouni, and D. Hassiakos Soluble Fas Concentrations in the Follicular Fluid and Oocyte-Cumulus Complex Culture Medium From Women Undergoing In Vitro Fertilization: Association With Oocyte Maturity, Fertilization, and Embryo Quality Reproductive Sciences, December 1, 2004; 11(8): 566 - 569. [Abstract] [PDF] |
||||
![]() |
F. J. Rubio Pomar, B. A.J. Roelen, K. A. Slot, H. T.A. van Tol, B. Colenbrander, and K. J. Teerds Role of Fas-Mediated Apoptosis and Follicle-Stimulating Hormone on the Developmental Capacity of Bovine Cumulus Oocyte Complexes In Vitro Biol Reprod, September 1, 2004; 71(3): 790 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. MALAMITSI-PUCHNER, A. SARANDAKOU, S. BAKA, D. HASIAKOS, E. KOUSKOUNI, and G. CREATSAS In Vitro Fertilization: Angiogenic, Proliferative, and Apoptotic Factors in the Follicular Fluid Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 124 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Embree-Ku and K. Boekelheide Absence of p53 and FasL Has Sexually Dimorphic Effects on Both Development and Reproduction Experimental Biology and Medicine, July 1, 2002; 227(7): 545 - 553. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |